ASCENDIS
"ASCENDIS" is a word mark owned by Ascendis Pharma A/S, filed at the CIPO on February 27, 2017. It is registered and covers classes 5, 42 and 45.
- Status
- Registered
- Since September 6, 2019
- Filed
- February 27, 2017
- Registered
- September 6, 2019
- Expires
- September 6, 2029
- Application no.
- 1824725
- Registration no.
- TMA1053020
- Office
- CIPO
- Canadian Intellectual Property Office
- Mark type
- Word mark
- 3 classes
Who owns ASCENDIS
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Ascendis Pharma A/S
Denmark
Representative
Smart & Biggar LP
Smart & Biggar LP
What the mark covers
The products and services ASCENDIS is filed for, grouped by Nice class.
Pharmaceutical and veterinary preparations for the treatment of physical and mental illness, namely, pharmaceutical preparations for the treatment of diseases, disorders and infections of the endocrine system, namely, growth and thyroid disorders, growth hormone deficiency, hypoparathyroidism, achondroplasia, diabetes, fibroblast growth factor receptor(FGFR)-related skeletal disorders, oncology, ophthalmology, infectious diseases and disorders namely, Intestinal infectious diseases, Infections with a predominantly sexual mode of transmission, Viral infections of the central nervous system, Arthropod-borne viral fevers and viral haemorrhagic fevers, Viral infections characterized by skin and mucous membrane lesions, Human immunodeficiency virus [HIV] disease, Mycoses, Protozoal diseases, Helminthiases, enzyme replacement therapy for the treatment of lysosomal storage diseases, anti-inflammatory disease, pain, namely, for the relief of pain and for the treatment of chronic pain, respiratory system disorder, autoimmune disorders, vaccines for human and veterinary use , non-alcoholic steatohepatitis, psychiatric and other brain diseases and disorders, namely, anxiety, mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, multiple sclerosis, bone diseases, CNS diseases, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, myopathies, namely, muscular diseases caused by structural and functional abnormalities of skeletal muscle tissue, namely muscular dystrophies, congenital muscular dystrophies, congenital myopathies, distal myopathies, other myopathies namely, myofibrillar, incusion body, myotonic syndromes, ion channel muscle diseases, malignant hyoperthermias, metabolic myopathies, congenital myasthenic syndromes, sarcopenia, muscle atrophy and cachexia and metabolic diseases of muscle, metabolic myopathies, mintochondria myopathies namely, muscular dystrophy, mucopolysaccharideoses, and cancer, obesity, wound healing, the hormonal system, namely growth hormone deficiency, diabetes and angiogenesis, the ophthalmological system, namely angiogenesis, the angiogenic system, the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, the immune system, namely, immunologic diseases, namely, autoimmune diseases and immunologic deficiency syndromes, the cardio-vascular system, the metabolic system, namely, diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, the respiratory system, the musculo-skeletal system, namely, growth hormone deficiency, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, the genitourinary system, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of inflammatory disorders, namely, anti-inflammatories; pharmaceutical preparations for use in dermatology, namely, dermatitis, eczema, psoriasis, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; sanitary preparations for medical purposes, namely, sanitizing wipes, disinfectants for medical instruments, adhesive tapes for medical purposes, dietetic foods, namely, dietetic sugar substitutes adapted for medical use, all-purpose disinfectants for sanitary purposes; fungicides, herbicides
Scientific research within the medical, pharmaceutical and bacteriological area and providing scientific consultancy and information in the fields of pharmaceuticals, vaccines and medicines and bacteriology, conducting of tests regarding medical applications; packaging design, designing and development of medical equipment, designing pharmaceutical and medical preparations, preparation of pharmaceutical formulations, design and development of granulation technology and tablet technology and providing scientific consultancy and information relating to the design and development of granulation technology and tablet technology; Scientific research within the medical, pharmaceutical and bacteriological area; providing scientific consultancy and information in the fields of pharmaceuticals, vaccines and medicines and bacteriology; testing of pharmaceuticals; packaging design, designing and development of medical equipment; developing pharmaceutical and medical preparations; design and development of pharmaceutical formulations; design and development of granulation technology and tablet technology; providing scientific consultancy and information relating to the design and development of granulation technology and tablet technology
Licensing of industrial property, legal services
What has happened so far
Steps recorded by the CIPO, newest first.
- Agent Changed; Transferred From: 12 To: 59
- Agent Changed; From: 26 To: 12
- Registered
- Registration Fee Notice Sent
- Registration Pending
- Advertised; Vol.66 Issue 3365
- Approved; APPROVED BY PROGRAM EX200M1
- Approval Notice Sent
- Correspondence Created
- Examiner's First Report
4 earlier steps on the official record.
About ASCENDIS
Who owns the trademark "ASCENDIS"?
The CIPO trademark "ASCENDIS" (application 1824725) is owned by Ascendis Pharma A/S.
What is the status of "ASCENDIS"?
Its status at the CIPO is: registered.
When was "ASCENDIS" registered?
It was registered on September 6, 2019 and is due to expire on September 6, 2029.
Get this data via the API
Everything on this page comes from the Signa API. Pull ASCENDIS and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019deb63-69c5-75a9-9d35-183b5195f190
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019deb63-69c5-75a9-9d35-183b5195f190",
"object": "trademark",
"mark_text": "ASCENDIS",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "CA",
"application_number": "1824725",
"filing_date": "2017-02-27",
"nice_classes": [
5,
42,
45
],
"owners": [
{
"name": "Ascendis Pharma A/S",
"entity_id": "ent_019eb711-cfef-70e8-9cf4-4a4fa9a981de"
}
]
}